C. Pallud

1.5k total citations
32 papers, 1.2k citations indexed

About

C. Pallud is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, C. Pallud has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Cancer Research and 11 papers in Genetics. Recurrent topics in C. Pallud's work include Breast Cancer Treatment Studies (12 papers), Estrogen and related hormone effects (10 papers) and HER2/EGFR in Cancer Research (6 papers). C. Pallud is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Estrogen and related hormone effects (10 papers) and HER2/EGFR in Cancer Research (6 papers). C. Pallud collaborates with scholars based in France, Netherlands and Belgium. C. Pallud's co-authors include Edwin Milgröm, M Brunet, K. Hacène, Christian Duval, A.M. Mandard, P C Clahsen, A Delobelle-Deroïde, Marc J. van de Vijver, Marie-France Pichon and Rosette Lidereau and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

C. Pallud

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Pallud France 18 700 479 387 342 183 32 1.2k
Jeannine Geneix France 15 630 0.9× 561 1.2× 962 2.5× 207 0.6× 121 0.7× 16 1.6k
Alessandra Bersiga Italy 16 641 0.9× 658 1.4× 458 1.2× 146 0.4× 149 0.8× 31 1.2k
Nikita Makretsov Canada 14 593 0.8× 380 0.8× 682 1.8× 136 0.4× 164 0.9× 19 1.4k
John Cairns United Kingdom 7 835 1.2× 268 0.6× 455 1.2× 188 0.5× 58 0.3× 13 1.1k
Holger Dieterich Switzerland 11 793 1.1× 579 1.2× 736 1.9× 192 0.6× 55 0.3× 14 1.6k
Andrew Berchuck United States 10 375 0.5× 203 0.4× 560 1.4× 149 0.4× 84 0.5× 11 1.1k
Lydia Sánchez Spain 19 580 0.8× 224 0.5× 642 1.7× 166 0.5× 213 1.2× 25 1.3k
Frank Mross Switzerland 3 515 0.7× 362 0.8× 521 1.3× 105 0.3× 50 0.3× 7 1.0k
S M Edgerton United States 13 1.1k 1.6× 661 1.4× 748 1.9× 216 0.6× 43 0.2× 14 1.7k
Elvira Benini Italy 17 1.0k 1.5× 549 1.1× 741 1.9× 162 0.5× 46 0.3× 30 1.5k

Countries citing papers authored by C. Pallud

Since Specialization
Citations

This map shows the geographic impact of C. Pallud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Pallud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Pallud more than expected).

Fields of papers citing papers by C. Pallud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Pallud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Pallud. The network helps show where C. Pallud may publish in the future.

Co-authorship network of co-authors of C. Pallud

This figure shows the co-authorship network connecting the top 25 collaborators of C. Pallud. A scholar is included among the top collaborators of C. Pallud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Pallud. C. Pallud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pallud, C., J M Guinebretière, K. Hacène, et al.. (2005). Tissue expression and serum levels of the oncoprotein HER-2/neu in 157 primary breast tumours.. PubMed. 25(2B). 1433–40. 20 indexed citations
2.
Hüe, Olivier, et al.. (2002). Alactic Anaerobic Performance in Subjects with Sickle Cell Trait and Hemoglobin AA. International Journal of Sports Medicine. 23(3). 174–177. 12 indexed citations
3.
McDermott, Ray, Frédéric Beuvon, C. Pallud, et al.. (2002). Tumor Antigens and Antigen-Presenting Capacity in Breast Cancer. Pathobiology. 70(6). 324–332. 24 indexed citations
5.
Lidereau, Rosette, François Eisinger, M.H. Champème, et al.. (2000). Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer.. PubMed. 60(5). 1206–10. 53 indexed citations
6.
Clahsen, P C, C.J.H. Van de Velde, Christian Duval, et al.. (1999). The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices fornode-negative breast cancer. European Journal of Surgical Oncology. 25(4). 356–363. 78 indexed citations
7.
Clahsen, P C, C J van de Velde, Christian Duval, et al.. (1998). p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer.. Journal of Clinical Oncology. 16(2). 470–479. 144 indexed citations
8.
Pallud, C., et al.. (1997). Infected ossified lingual thyroid goitre. European Journal of Radiology. 24(3). 230–236.
9.
Gilles, R., et al.. (1996). Contrast-enhanced CT: value for diagnosing local breast cancer recurrence after conservative treatment.. Radiology. 200(3). 631–638. 39 indexed citations
10.
Scholl, Suzy, Ivan Bièche, C. Pallud, et al.. (1996). Relevance of multiple biological parameters in breast cancer prognosis. The Breast. 5(1). 21–30. 9 indexed citations
11.
Clahsen, P C, Jan Hein van Dierendonck, Christian Duval, et al.. (1996). Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy. British Journal of Cancer. 74(1). 78–85. 104 indexed citations
12.
Scholl, Suzy, C. Pallud, Frédéric Beuvon, et al.. (1994). Anti-Colony-Stimulating Factor-1 Antibody Staining in Primary Breast Adenocarcinomas Correlates With Marked Inflammatory Cell Infiltrates and Prognosis. JNCI Journal of the National Cancer Institute. 86(2). 120–126. 195 indexed citations
13.
Pallud, C., V Le Doussal, M. Pichon, et al.. (1993). Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumours. Histopathology. 23(3). 249–256. 18 indexed citations
14.
Briffod, M, Frédérique Spyratos, K. Hacène, et al.. (1992). Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysis. Cytometry. 13(3). 250–258. 25 indexed citations
16.
Pichon, M., C. Pallud, K. Hacène, & Edwin Milgröm. (1992). Prognostic value of progesterone receptor after long-term follow-up in primary breast cancer. European Journal of Cancer. 28(10). 1676–1680. 9 indexed citations
18.
Spyratos, F., K. Hacène, M. Tubiana-Hulin, C. Pallud, & M Brunet. (1989). Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. European Journal of Cancer and Clinical Oncology. 25(8). 1233–1240. 34 indexed citations
19.
Brailly, Sylvie, et al.. (1988). Radioimmunoassay of progesterone receptor in human tissues: application to breast cancer. Journal of Endocrinology. 116(3). 427–434. 9 indexed citations
20.
Doussal, V Le, et al.. (1980). [Deceptive form of anaplastic carcinoma of the breast simulating a lymphoma: cytologic, histologic and ultrastructural examination of two cases (author's transl)].. PubMed. 28(4). 238–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026